After-Hours Stock Movers: Berkeley Lights, Sutro Biopharma, BioNTech SE and more

StreetInsider2022-01-06

After-Hours Stock Movers:

Berkeley Lights, Inc., (Nasdaq: BLI) 25% LOWER; Eric D. Hobbs, Ph.D., the company’s CEO and Board Member, will transition from his role to the president of the Antibody Therapeutics, to focus on growing the company’s largest business line. Provides outlook.

Sutro Biopharma, Inc. (NASDAQ: STRO) 12.8% LOWER; provided a clinical update from the Company's ongoing, fully enrolled, dose-expansion Phase 1 study of STRO-002, a folate receptor alpha (FolR)-targeting antibody-drug conjugate (ADC), for patients with advanced ovarian cancer. Discussion of these data will be held at a STRO-002 Virtual Event at 2 pm PT/5 pm ET today.

SomaLogic (NASDAQ: SLGC) 8.1% HIGHER; announced a worldwide strategic collaboration with Illumina, a global next-generation sequencing technology leader. The multi-year partnership agreement will bring together genomics and proteomics technology platforms in a major commercial partnership to better enable and empower proteomics and multi-omics research worldwide. As part of the agreement:

Magenta Therapeutics, Inc. (NASDAQ: MGTA) 9% HIGHER; upgraded to Buy at Goldman Sachs.

Turtle Beach Corporation (Nasdaq: HEAR) 4.4% LOWER; expects to report full year 2021 revenue of approximately $365 million, in line with previously provided guidance of $365 to $380 million. Full year Adjusted EBITDA for 2021 is expected to be within, although at the lower end, of the previously provided guidance range of $36 to $44 million reflecting expected revenue. (*Consensus sees FY21 revenue of $374.8 million)

BioNTech SE (NASDAQ: BNTX) 1.6% HIGHER; CDC Advisers Recommend BioNTech/Pfizer (NYSE: PFE) Booster Shot For Kids Ages 12-17 - Bloomberg.

Dynavax Technologies (NASDAQ: DVAX) 2.1% HIGHER; Goldman Sachs reinstates coverage with a Buy rating and a price target of $38.00.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

发表看法
1